Magazine Article | September 3, 2018

One-On-One With Tony Coles, CEO Of Yumanity Therapeutics

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

While in Boston for the 2018 BIO International Convention, I escaped the hustle and bustle of the show for a few hours to interview an executive whom I had wanted to meet for years — Tony Coles, M.D. The interview took place in Cambridge at the small, understated offices of Yumanity Therapeutics, a biotech launched in December of 2014 that focuses on therapies for Alzheimer's, Parkinson's, and ALS. Coles, the company's chairman and CEO, met me wearing a black mock turtleneck, jeans, and his trademark round-framed glasses.